Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

The future of basic science research and stroke: hubris and translational stroke research.

Lyden P.

Int J Stroke. 2011 Oct;6(5):412-3. doi: 10.1111/j.1747-4949.2011.00657.x. No abstract available.

PMID:
21951405
2.

The future of stroke neurology.

van Gijn J.

J Neurol. 2004 Feb;251(2):235-9. Review. No abstract available.

PMID:
14991364
3.

Update on recent progress in drug treatment for acute ischemic stroke.

Devuyst G, Bogousslavsky J.

J Neurol. 2001 Sep;248(9):735-42. Review. No abstract available.

PMID:
11596776
4.

Future directions in IAT: better studies, better selection, better timing and better techniques.

Yoo AJ, Leslie-Mazwi TM, Jovin TG.

J Neurointerv Surg. 2013 May;5 Suppl 1:i1-6. doi: 10.1136/neurintsurg-2013-010741. Review. No abstract available.

PMID:
23572460
5.

The past is the future: innovative designs in acute stroke therapy trials.

Krams M, Lees KR, Berry DA.

Stroke. 2005 Jun;36(6):1341-7. No abstract available.

6.

[Advanced therapy strategies in neurological diseases: present and perspectives].

Ludolph AC, Kassubek J.

Nervenarzt. 2011 Aug;82(8):955-6. doi: 10.1007/s00115-011-3256-0. German. No abstract available.

PMID:
21796437
7.

Drug research: plug the real brain drain.

Schwab ME, Buchli AD.

Nature. 2012 Mar 14;483(7389):267-8. doi: 10.1038/483267a. No abstract available.

PMID:
22422244
8.

Neuroprotection and stroke: time for a compromise.

Young AR, Ali C, DuretĂȘte A, Vivien D.

J Neurochem. 2007 Nov;103(4):1302-9. Review.

9.

Translating promising preclinical neuroprotective therapies to human stroke trials.

Cook DJ, Tymianski M.

Expert Rev Cardiovasc Ther. 2011 Apr;9(4):433-49. doi: 10.1586/erc.11.34. Review.

PMID:
21517728
10.

Stroke management.

Gubitz G, Sandercock P.

Clin Evid. 2002 Dec;(8):169-83. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):206-20.

PMID:
12603876
11.

Stroke management.

Gubitz G, Sandercock P.

Clin Evid. 2002 Jun;(7):161-74. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):169-83.

PMID:
12230642
12.

Next steps in clinical trial redesign.

Nicholas J.

J Natl Cancer Inst. 2012 Jan 18;104(2):90-2. doi: 10.1093/jnci/djr550. No abstract available.

13.

Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.

Fisher M; Stroke Therapy Academic Industry Roundtable..

Stroke. 2003 Jun;34(6):1539-46. Review.

14.

Potentially effective therapies for acute ischemic stroke.

Fisher M.

Eur Neurol. 1995;35(1):3-7. Review.

PMID:
7737243
15.

The Virtual International Stroke Trials Archive (VISTA): results and impact on future stroke trials and management of stroke patients.

Weimar C, Ali M, Lees KR, Bluhmki E, Donnan GA, Diener HC; VISTA Steering Committee..

Int J Stroke. 2010 Apr;5(2):103-9. doi: 10.1111/j.1747-4949.2010.00414.x.

PMID:
20446944
16.

Neuroprotection.

Lees KR.

Br Med Bull. 2000;56(2):401-12. Review.

17.

Recent advances in basic and translational stroke research.

Boltze J, Kranz A, Wagner DC, Reymann K, Reiser G, Hess DC.

Expert Rev Neurother. 2011 Feb;11(2):199-202. doi: 10.1586/ern.10.202.

PMID:
21306206
18.

Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.

Savitz SI, Fisher M.

Ann Neurol. 2007 May;61(5):396-402. Review.

PMID:
17420989
19.

[Human, economics and social sciences: rebounds of ideas on genomics and clinical trials].

Julian-Reynier C.

Med Sci (Paris). 2012 Mar;28 Spec No 1:3-4. doi: 10.1051/medsci/2012281s101. French. No abstract available.

20.

Current treatments in neurology: stroke.

Markus HS.

J Neurol. 2005 Mar;252(3):260-7. Review.

PMID:
15742106
Items per page

Supplemental Content

Support Center